Voluntarily taking a back—but important—seat. DJO Incorporated has announced the planned retirement of Leslie H. Cross, President and CEO. Cross will transition to non-executive Chairman of the DJO Board of Directors between now and June 30, 2011.
Les Cross Transitions at DJO
1 min read Premium comments
“It is my good fortune to complete my professional career as DJO’s President and Chief Executive Officer, ” said Les Cross in the news release. “Over the past 20-plus years, I have worked with many talented people who have contributed to DJO’s success and growth, and the company is well-positioned to continue that growth. As we enter 2011, DJO is in strong condition, has good momentum in its markets and many exciting opportunities before it. I feel very comfortable that now is the right time to move into a role that will permit me to spend more time with my family.”
In conjunction with the DJO Board of Directors, Les Cross has begun searching for someone to step into the shoes of the (soon to be) former CEO and President. The company notes that it will make an announcement regarding the appointment of the successor prior to Mr. Cross’ transition.
As for his role going forward, Cross told OTW,
The DJO Board of Directors has asked me to take on the role of Chairman of the Board which I have proudly accepted, and will remain a vital and important part of the DJO team. I continue to believe there will be great success in the future for this company.
Regarding his hopes for the company in the next five years, Cross commented to OTW,
Through DJO’s leadership, we will continue to improve patients’ lives by providing products and services that address the continuum of patient care, from injury prevention to rehabilitation after surgery, injury or from degenerative disease, enabling people to regain or maintain their natural motion.
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.